Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life

21 de junho de 2011 atualizado por: Charite University, Berlin, Germany

Standardized Skin Care Regimen in the Diaper Area: a Prospective, Randomized Clinical Study on Skin Barrier Function and Epidermal IL-1α

Study design:

The purpose of the present study is to analyse of the influence of the application of the skin care products on the diaper area (Factor A) and the application of a cotton wool cloth, moistened with clear water on the diaper area (Faktor B) on the skin barrier function of the newborns during the first four weeks. Additionally, the microbiological colonisation of the skin will be observed. After four weeks all infants in both groups will obtain wet wipe and after 8 weeks a facultative measurement will be performed.

Primary and secondary end points:

In the present study, as a primary end point TEWL on the buttock was chosen, because the significant difference between the infants who were bathed and washed in the previous study was found.

Secondary end points are the TEWL on the other measuring points, pH-value and SCH. Additionally, secondary end points are the D-Squame method and the cytokine measurement with Sebutapes.

Hypotheses:

The intention of the study is to evaluate, whether the using of wet wipe on the diaper area has an influence on the TEWL of the newborns. The following hypotheses are present below:

H0 (Null hypothesis): The TEWL is indistinguishable between infants who get cleaned with wet wipe on the diaper area and infants who get cleaned with a cotton wool cloth, moistened with clear water on the diaper area, i.e.

TEWL clear water is equal TEWL wet wipe against H1 (Alternative hypothesis - bilateral): The TEWL is distinguishable between infants who get cleaned with wet wipe on the diaper area and infants who get cleaned with a cotton wool cloth, moistened with clear water on the diaper area, i.e.

TEWL clear water is not equal TEWL wet wipe

Visão geral do estudo

Status

Concluído

Descrição detalhada

Method and number of subjects:

Monocenter, prospective, randomized study with two parallel groups. To get reliable results, the number of male and female newborns to be included in this study is 40.

The group of 40 healthy full-term newborn babies will be divided into 2 groups:

Number of groups and subjects Application of skin care products

  1. 01-19 Using of wet wipe during the diaper changes
  2. 20-40 Using a cotton wool cloth, moistened with clear water during the diaper changes. The measurement take place at the Clinical Research Center for Hair and Skin Physiology, at the Department of Dermatology, Campus Charité Mitte and also at the Department of Neonatology Campus Charité Mitte, Charité-Universitätsmedizin Berlin.

Study plan:

Application:

All newborns will obtain a standard skin care, according to division into one of the followings groups: it will be used wet wipe during the diaper changes or a cotton wool cloth moistened with clear water. Additionally, the infants of both groups will be bathed twice a week according to following standard schema. The infant will be submerged in bathtub half filled with water, up to the shoulder.The water temperature should be ca. 370C, pH 7.9-8.2 and the bathing should not require longer than 5 minutes.

Inclusion criteria:

All healthy (i.e. meeting none of the non-inclusion criteria) term newborns are possible candidates for the study. The following criteria must be met for enrollment in the study:

  1. Male and female term newborns from 37 completed weeks of gestation, age ≤ 48 hours
  2. Written informed parental consent

Non-inclusion criteria:

  • Any critically ill term newborn, i.e. septic infants, infants born with serious congenital malformation/defects, asphyxia, hydronephrosis, severe intracranial hemorrhage
  • Newborns with known immunodeficiency
  • Newborns with pre-existing skin disease with eruptions covering more than 50% of body surface i.e. congenital ichthyosis, congenital candidiasis
  • Newborn has relevant skin maceration, which influence the measurements or is communicable i.e. urticaria or herpes
  • Any acutely or chronically ill newborn with temperatures below 35°C or above 40°C
  • Newborn is taking part in another study or is during a term of exclusion of a study.

Tipo de estudo

Observacional

Inscrição

44

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra de Probabilidade

População do estudo

group of 40 healthy full-term newborn babies

Descrição

Inclusion Criteria:

  • All healthy (i.e. meeting none of the non-inclusion criteria) term newborns are possible candidates for the study. The following criteria must be met for enrollment in the study:

    1. Male and female term newborns from 37 completed weeks of gestation, age ≤ 48 hours
    2. Written informed parental consent

Exclusion Criteria:

  • Any critically ill term newborn, i.e. septic infants, infants born with serious congenital malformation/defects, asphyxia, hydronephrosis, severe intracranial hemorrhage

    • Newborns with known immunodeficiency
    • Newborns with pre-existing skin disease with eruptions covering more than 50% of body surface i.e. congenital ichthyosis, congenital candidiasis
    • Newborn has relevant skin maceration, which influence the measurements or is communicable i.e. urticaria or herpes
    • Any acutely or chronically ill newborn with temperatures below 35°C or above 40°C
    • Newborn is taking part in another study or is during a term of exclusion of a study

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
BW= using baby wipes and CW= using cotton wool
wet wipe, cotton wool
Group 1 (BW),(n= 01-19):Using of wet wipe during the diaper changes Group 2 (CW),(n=20-40):Using a cotton wool cloth, moistened with clear water during the diaper changes.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
TEWL
Prazo: second day of life, 14 day of life and 28 day of life
TEWL= transepidermal waterloss
second day of life, 14 day of life and 28 day of life

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
pH
Prazo: second day of life, 14 day of life and 28 day of life
skin pH
second day of life, 14 day of life and 28 day of life
SCH
Prazo: 2nd, 14th and 28th day of life
SCH= stratum corneum hydration
2nd, 14th and 28th day of life
D-Squame
Prazo: 2nd, 14th and 28th day of life
D-Squame= special adhesive skin foils
2nd, 14th and 28th day of life
Interleukin-1α
Prazo: 2nd, 14th and 28th day of life
Interleukin 1 alpha= cytokine
2nd, 14th and 28th day of life
microbiological colonisation
Prazo: 2nd, 14th and 28th day of life
microbiological colonisation of umbilical an buttock region
2nd, 14th and 28th day of life

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Colaboradores

Investigadores

  • Investigador principal: Ulrike Blume-Peytavi, MD, PhD, Department of Dermatology, Charite-Universitätsmedizin, Berlin

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de maio de 2007

Conclusão do estudo

1 de outubro de 2007

Datas de inscrição no estudo

Enviado pela primeira vez

26 de maio de 2010

Enviado pela primeira vez que atendeu aos critérios de CQ

26 de maio de 2010

Primeira postagem (Estimativa)

27 de maio de 2010

Atualizações de registro de estudo

Última Atualização Postada (Estimativa)

22 de junho de 2011

Última atualização enviada que atendeu aos critérios de controle de qualidade

21 de junho de 2011

Última verificação

1 de maio de 2007

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • CRC/wet wipe

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em Postnatal Skin Physiology

3
Se inscrever